Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Matthew W. Jackson"'
Autor:
Brian D. Kavanagh, Matthew W. Jackson, Bernard L. Jones, Paul Maroni, Thomas J. Pugh, Steven J. Frank, Usama Mahmood, Arya Amini, Rajat J. Kudchadker
Publikováno v:
Brachytherapy. 16:790-796
Conventional prostate cancer risk stratification results in considerable heterogeneity within each prognostic group. Men with pathologic grade Group 4 (Gleason score 8) but otherwise low-risk features have been identified as a favorable subset of hig
Publikováno v:
Leukemialymphoma. 60(5)
Elderly patients with classical Hodgkin lymphoma (cHL) are understudied and poorly defined. The National Cancer Data Base was queried for adults with cHL diagnosed 2004-2013: 22,547 age 18-39, 12,841 age 40-59, and 10,873 age ≥60 were identified. T
Autor:
Chad G. Rusthoven, Arya Amini, Karyn A. Goodman, Bernard L. Jones, Tracey E. Schefter, Matthew W. Jackson
Publikováno v:
The Cancer Journal. 22:237-242
Purpose Most patients with intrahepatic cholangiocarcinoma present with locally advanced disease not amenable to surgical resection. For these inoperable patients, chemotherapy alone is generally considered the standard of care, with limited data reg
Autor:
Chad G. Rusthoven, Christine M. Fisher, Norman Yeh, Rachel Rabinovitch, Bernard L. Jones, Arya Amini, Matthew Koshy, Matthew W. Jackson
Publikováno v:
Annals of Oncology. 27:818-827
BACKGROUND Following neoadjuvant chemotherapy (NAC), the optimal strategies for postmastectomy radiotherapy (PMRT) and regional nodal irradiation (RNI) after breast-conserving surgery (BCS) are controversial. In this analysis, we evaluate the impact
Publikováno v:
American Journal of Hematology. 91:476-480
Primary mediastinal B-cell lymphoma (PMBCL) is an uncommon lymphoma for which existing data is limited. We utilized the National Cancer Database (NCDB) to evaluate PMBCL and the impact of radiotherapy (RT) on outcomes in the years following FDA appro
Autor:
Matthew W. Jackson, J.H. Petit, J.W. Ridings, Rachel Rabinovitch, S. Veazey, Christine M. Fisher, Debashis Ghosh
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:S41-S42
Autor:
Christine M. Fisher, Tyler P. Robin, Arya Amini, Matthew W. Jackson, Tracey E. Schefter, William A. Stokes, Carolyn Lefkowits
Publikováno v:
American journal of clinical oncology. 41(10)
The objective of this study is to characterize patterns of utilization of adjuvant chemotherapy (CT) and radiotherapy (RT) in the posthysterectomy management of uterine carcinosarcoma (UCS) in the United States.We queried the National Cancer Database
Autor:
Chad G. Rusthoven, S. Reed Plimpton, William A. Stokes, Arya Amini, Matthew W. Jackson, Peter Kabos, Nicole Kounalakis, Rachel Rabinovitch, Christine M. Fisher
Publikováno v:
Clinical breast cancer. 18(3)
Background While the roles of hypofractionated (HFxn) radiotherapy and lumpectomy boost in the adjuvant management of invasive breast cancer are supported by the results of clinical trials, randomized data supporting their use for ductal carcinoma in
Autor:
J. P. Cravens, Gregory S. Winters, Jessica Tumlinson, K. B. Persson, Anthony O. Sawka, Philip M. Wilcox, John V. Vallerga, Thomas K. Greathouse, John S. Eterno, B. Trantham, Oswald H. W. Siegmund, Michael K. Young, Matthew W. Jackson, Henry Sykes, Adrian Martin, S. Persyn, Robert Klar, Denis Grodent, Michael W. Davis, François Denis, Bertrand Bonfond, Walter L. Lockhart, Jean-Claude Gérard, Benjamin M. Piepgrass, Cherie L. Rhoad, Brandon Walther, Benoit Marquet, David C. Slater, R. Raffanti, John Beshears, G. Randall Gladstone, G. Dirks, Maarten H. Versteeg
Publikováno v:
Space Science Reviews. 213:447-473
The ultraviolet spectrograph instrument on the Juno mission (Juno-UVS) is a long-slit imaging spectrograph designed to observe and characterize Jupiter’s far-ultraviolet (FUV) auroral emissions. These observations will be coordinated and correlated
Autor:
Brian D. Kavanagh, John D. Mitchell, Bernard L. Jones, Thomas Guerrero, Richard Castillo, Chad G. Rusthoven, Edward M. Castillo, Moyed Miften, Yevgeniy Vinogradskiy, Matthew W. Jackson, Leah Schubert
Publikováno v:
Med Phys
PURPOSE: A primary treatment option for lung cancer patients is surgical resection. Patients who have poor lung function prior to surgery are at increased risk of developing serious and life‐threatening complications after surgical resection. Surge